Patient treatment preference in metastatic prostate cancer.
40 male patients with metastatic prostate cancer given a choice of medical castration with the LHRH Analogue Goserelin (Zoladex) or surgical castration chose medical treatment. During a 15 month follow up only one patient decided to have an orchidectomy and this was because of treatment expense.
Creagh
T
T
D000368:Aged; D000369:Aged, 80 and over; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D005500:Follow-Up Studies; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D015996:Survival Rate; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin